Related references
Note: Only part of the references are listed.NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Prenylated C17orf37 Induces Filopodia Formation to Promote Cell Migration and Metastasis
Subhamoy Dasgupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The DNA-recognition fold of Sso7c4 suggests a new member of SpoVT-AbrB superfamily from archaea
Chun-Hua Hsu et al.
NUCLEIC ACIDS RESEARCH (2011)
Turn motif phosphorylation negatively regulates activation loop phosphorylation in Akt
D. Hiraoka et al.
ONCOGENE (2011)
Resonance assignments of human C35 (C17orf37) protein, a novel tumor biomarker
Chun-Jiun Yang et al.
BIOMOLECULAR NMR ASSIGNMENTS (2010)
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk
E. Katz et al.
BRITISH JOURNAL OF CANCER (2010)
Multiple catalytically active thioredoxin folds: a winning strategy for many functions
Emilia Pedone et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
NMR and biophysical elucidation of structural effects on extra N-terminal methionine residue of recombinant amphibian RNases from Rana catesbeiana
Chun-Hua Hsu et al.
JOURNAL OF BIOCHEMISTRY (2010)
Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells
S. Dasgupta et al.
ONCOGENE (2009)
Solution structure of selenoprotein W and NMR analysis of its interaction with 14-3-3 proteins
Finn L. Aachmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
High-throughput identification of catalytic redox-active cysteine residues
Dmitri E. Fomenko et al.
SCIENCE (2007)
Thioredoxin and related molecules - From biology to health and disease
Christopher Horst Lillig et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer
Elizabeth E. Evans et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The origami of thioredoxin-like folds
Jonathan L. Pan et al.
PROTEIN SCIENCE (2006)
Molecular dissection of 17q12 amplicon in upper gastrointestinal adenocarcinomas
Nazif Maqani et al.
MOLECULAR CANCER RESEARCH (2006)
Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer
P Kauraniemi et al.
ENDOCRINE-RELATED CANCER (2006)
AKT signaling in normal and malignant cells
JR Testa et al.
ONCOGENE (2005)
The CCPN data model for NMR spectroscopy: Development of a software pipeline
WF Vranken et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance
T Yasukawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural classification of thioredoxin-like fold proteins
Y Qi et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt
H Murata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Solution structure of the cytotoxic RNase 4 from oocytes of bullfrog Rana catesbeiana
CH Hsu et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Crystal structure of an inactive Akt2 kinase domain
X Huang et al.
STRUCTURE (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation
J Yang et al.
MOLECULAR CELL (2002)
Multidimensional NMR methods for protein structure determination
V Kanelis et al.
IUBMB LIFE (2001)
Ten years of protein kinase B signalling: a hard Akt to follow
DP Brazil et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Share Paper
